12:00 AM
 | 
May 08, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

BZL Biologics preclinical data

BZL said that mice treated with J591 conjugated to the maytansinoid toxin DM-1 gave complete regression of well-established large prostate tumors, and in some...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >